NCT05821023 is a NA clinical trial of messages in Breast Cancer Screening, sponsored by Johns Hopkins University.

Who is sponsoring NCT05821023?

NCT05821023 is sponsored by Johns Hopkins University.

What drugs are being tested in NCT05821023?

Interventions in NCT05821023: messages.

What condition does NCT05821023 study?

NCT05821023 studies Breast Cancer Screening.

Is NCT05821023 still recruiting?

NCT05821023 is currently completed. Last updated 14 February 2024.

Last reviewed 2024-02-14 · How we verify

NCT05821023

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Messaging Strategies to Reduce Breast Cancer Over-screening in Older Women

Completed NA Last updated 14 February 2024

What this trial tests

NA trial testing messages in Breast Cancer Screening in 4,173 participants. Completed in 19 June 2023.

Timeline

12 May 2023

Primary endpoint
19 June 2023

19 June 2023

Quick facts

Lead sponsor	Johns Hopkins University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	health services research
Enrollment	4,173
Start date	12 May 2023
Primary completion	19 June 2023
Estimated completion	19 June 2023
Sites	1 location across United States

Drugs / interventions tested

messages

Conditions studied

Breast Cancer Screening — all drugs for Breast Cancer Screening →

Sponsor

Johns Hopkins University

Who can join

65 and older, female only, with Breast Cancer Screening. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is an online survey experiment with data collection over 2 time points two weeks apart. This is Aim 2 of a three-aim R01 project; overall project goal is to better understand how messages from different sources interact to affect older women's breast cancer screening decisions. In this current project, the investigators propose to test the effect of combined exposure to a clinician message + a message from another source (i.e. family/friend or media) on older women's breast cancer screening beliefs, attitudes, and intentions.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Effect of Messaging on Support for Breast Cancer Screening Cessation Among Older US Women: A Randomized Clinical Trial.
Schoenborn NL, Gollust SE, Nagler RH, Pollack CE, et al · · 2024 · cited 11× · PMID 39158912 · DOI 10.1001/jamanetworkopen.2024.28700
The effect of conflicting versus consistent messaging on older women's support for breast cancer screening cessation.
Schoenborn NL, Gollust SE, Pollack CE, Schonberg MA, et al · · 2025 · PMID 39874687 · DOI 10.1016/j.pec.2025.108675

Verify or expand the search:

Other recruiting trials for Breast Cancer Screening

Currently open trials in the same condition.

NCT07067788 — B.Brilliant Revelation Comparision Study · recruiting
NCT06934239 — A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detec · Phase 4 · recruiting
NCT07075679 — Screening Mammography: Single Reading by One Radiologist With AI vs. Double Reading by Two Radiologists (AI-BCSQ) · NA · recruiting
NCT06876610 — Application of CfDNA Methylation Detection in Auxiliary Diagnosis of Breast Cancer · recruiting
NCT07411443 — AI-Enhanced Imaging in Population Breast Cancer Screening · NA · recruiting

Other Johns Hopkins University trials

Trials by the same sponsor.

NCT06236542 — Tracheostomy Robotics and Cutting-edge Health Education for Airway Safety · NA · not yet recruiting
NCT07532252 — Daridorexant for Alcohol Use Disorder · Phase 2 · not yet recruiting
NCT06687655 — Impact of Exogenous Ketones on Sleep Apnea · Phase 1, PHASE2 · not yet recruiting
NCT07079111 — 3D Printed Occlusal Splints for Intraoperative Use · NA · not yet recruiting
NCT02998502 — The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05821023 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Johns Hopkins University
Last refreshed: 14 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05821023.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing